AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sunitibenz 12.5 Capsule

Prescription Icon
Prescription Required

Marketer

Admac Pharma Ltd

Salt Composition

Sunitinib (12.5mg)

Overview Sunitibenz 12.5 Capsule

Sunitinib 12.5mg capsules treat kidney and gastrointestinal stromal tumors. Its mechanism involves inhibiting specific enzymes crucial for cancer cell proliferation, thus reducing tumor size and growth rate. Administer this medication at the same time daily, with or without food, for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strict adherence to the prescribed regimen is vital; incorrect usage or overdose may lead to severe adverse events. Therapeutic effects might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include fatigue, nausea, vomiting, altered taste, decreased appetite, and diarrhea. Regular blood pressure and thyroid function monitoring is often recommended. Hypoglycemia, potentially severe enough to cause fainting, is possible, necessitating frequent blood sugar checks for diabetics and potential anti-diabetic medication dosage adjustments. Inform your physician of any pre-existing heart, liver, kidney, or bleeding disorders before commencing treatment. Drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.

Uses of Sunitibenz 12.5 Capsule

Managing kidney cancer and gastrointestinal stromal tumors.

Major Benefits of Sunitibenz 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sunitibenz 12.5 Capsules. These capsules can be administered with or without food, although consistent timing is recommended.

Common Side effects of Sunitibenz 12.5 Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Sunitibenz 12.5 Capsule:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Sunitibenz 12.5 Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

How Sunitibenz 12.5 Capsule works:

Sunitibenz 12.5 Capsules are an anticancer agent. Their mechanism involves targeting and inhibiting specific cell surface proteins (tyrosine kinases) crucial for cancer cell multiplication. Concurrently, they limit the formation of new blood vessels supplying the tumor, thus hindering the spread of cancerous cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Sunitibenz 12.5 Capsule is undetermined; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sunitibenz 12.5 Capsule during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sunitibenz 12.5 Capsule while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Sunitibenz 12.5 Capsules might lead to adverse effects that impair driving ability. Dizziness is a possible side effect. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Sunitibenz 12.5 Capsules without requiring any dosage modification.

LiverLiverSAFE IF PRESCRIBED

Patients with liver impairment can safely use Sunitibenz 12.5 Capsules without requiring a dosage modification.

What if you forget to take Sunitibenz 12.5 Capsule :

Omit any missed Sunitibenz 12.5 Capsule dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sunitibenz 12.5 Capsule

LabelValue
Type of Compound Indole- and pyrrole-containing compounds
Addictive None.
Medication Classification Cancer treatments

FAQs on Sunitibenz 12.5 Capsule

Follow your physician's instructions precisely when using Sunitibenz 12.5 Capsules. Prescribing should be limited to oncologists experienced in administering cancer therapies. Administer once daily, with or without food. Avoid grapefruit and grapefruit juice throughout your Sunitibenz 12.5 Capsule treatment to minimize potential adverse reactions.
While taking Sunitibenz 12.5 Capsules, skin lightening and hair thinning are possible. Patients might also develop dry, thickened, or cracked skin, blisters, or rashes on their hands and feet. These effects are typically temporary and resolve after treatment ends. However, Sunitibenz 12.5 Capsules can cause severe, potentially life-threatening skin reactions like extensive rashes or rapidly worsening skin sores. Report any signs of infection near a skin wound—including fever, pain, redness, swelling, or pus/blood discharge—to your physician immediately.
Sunitibenz 12.5 Capsule carries a risk of severe liver complications, potentially fatal. Report itching, jaundice (yellowing of eyes or skin), dark urine, or right upper abdominal pain or discomfort immediately to your physician. Liver function will be monitored via blood tests before and throughout Sunitibenz 12.5 Capsule treatment. Should liver problems arise, your doctor may suspend or discontinue the medication.
Sunitibenz 12.5 Capsule currently lacks generic alternatives. Its mechanism of action involves inhibiting a protein kinase enzyme, a surface protein on cancer cells that drives their growth and metastasis. This enzymatic blockage prevents cancer proliferation. Other medications that similarly target protein kinases include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
No research validates combining Sunitibenz 12.5 Capsules with other chemotherapy drugs. This medication treats gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, specifically when imatinib, an alternative cancer medication, proves ineffective or is unsuitable for the patient.
Sunitibenz 12.5 Capsule can lower blood glucose. Diabetic patients should monitor their blood sugar closely, as hypoglycemia, potentially leading to loss of consciousness, is a risk. Adjustments to anti-diabetic medication dosage may be necessary based on these regular blood sugar checks.
Sunitibenz 12.5 Capsule commonly elevates blood pressure. Consequently, consistent blood pressure monitoring is crucial. Report severe headache, dizziness, lightheadedness, or visual disturbances to your physician immediately. They may initiate blood pressure-lowering medication or temporarily suspend your treatment until your blood pressure normalizes.
Sunitibenz 12.5 Capsule
1,626
MRP 1,981
17% off